Center for Interventional Vascular Therapy
Investigator
Susheel Kodali, MD
Phone
212-342-0444
Email
sk2427@cumc.columbia.edu

Susheel K. Kodali, MD is the co-director of the Structual Heart & Valve Center at NewYork-Presbyterian/ Columbia University Medical Center. Dr. Kodali is also the director of the interventional cardiology fellowship program and an assistant professor in medicine at CUMC.

Board certified in interventional cardiology, endovascular medicine, and cardiovascular disease, Dr. Kodali specializes in the percutaneous treatment of coronary artery and structural heart disease, and cardiac catheterization.

Dr. Kodali was named New York Metro Area’s Top Doctor in 2012 and 2015 by Castle Connolly's Top Doctors™ and New York Magazine’s Top Doctors in 2012 and 2015. Dr. Kodali serves as the institutional co-investigator of the PARTNER trials and associated registries and is a member of the PARTNER trial steering committee.

Dr. Kodali attended medical school at The University of California, Los Angeles. He did his residency and a fellowship program in clinical cardiology at the University of California, San Francisco, and a fellowship program in interventional cardiology at Columbia University Medical Center.


Clinical Studies Managed By This Investigator:
Condition Study Title
Arterial Disease [ CLOSED ] A study for patients with aortic stenosis using new investigational device Evolut R
Valve Disease [ CLOSED ] Patients with severe aortic stenosis using Edwards SAPIEN 3 Transcatheter Heart Valve instead of surgery to treat aortic stenosis PARTNER 3
Heart Disease [ CLOSED ] COAPT Continued Access Study
Valve Disease APOLLO Trial for patients with Mitral regurgitation
Mitral Valve Disease [ CLOSED ] Edwards Cardioband System & medical therapy versus medical therapy alone in patients with functional mitral regurgitation and heart failure
Aortic Valve Disease [ CLOSED ] Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With Aortic Stenosis and no symptoms.
Heart Failure Transcatheter Aortic Valve Replacement plus medical management versus medical management alone in patients with ADvanced heart failure
Coronary Artery Disease [ CLOSED ] The REFLECT Trial
Mitral Valve Disease [ CLOSED ] PARTNER 3 Trial: Mitral Valve in Valve
Tricuspid Valve Disease [ CLOSED ] Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study
Mitral Valve Disease The CARILLON Trial: Mitral Contour System in Treating Functional Mitral Regurgitation Associated with Heart Failure
Mitral Valve Disease [ CLOSED ] Study of The Medtronic Intrepid Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation
Tricuspid Valve Disease CLASP II TR: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial in Patients with Tricuspid Regurgitation
Mitral Valve Disease [ CLOSED ] The CorCinch-HFrEF Study in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF)
Mitral Valve Disease [ CLOSED ] Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial in Patients with Mitral Regurgitation
Valve Disease [ CLOSED ] REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects (REPRISE IV)
Tricuspid Valve Disease TRILUMINATE Pivotal: Study of Cardiovascular Outcomes Treated with the TriClip Device in Patients with Severe Tricuspid Regurgitation
Aortic Valve Disease Portico NG Approval Study in Patients with Symptomatic Severe Aortic Stenosis
Mitral Valve Disease [ CLOSED ] The Half Moon Transcatheter Mitral Valve Repair (TMVr) Study
Mitral Valve Disease [ CLOSED ] Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation
Tricuspid Valve Disease TTVR Early Feasibility Study in Patients with Symptomatic Severe Tricuspid Regurgitation - Medtronic
Tricuspid Valve Disease TRISCEND ll PIVOTAL Study of the Edwards EVOQUE Tricuspid Valve Replacement System
Mitral Valve Disease MitraClip REPAIR MR Study in Patients with Primary Mitral Regurgitation
Aortic Valve Disease The Leaflex Early Feasibility Study Protocol in Patients with Symptomatic Severe Aortic Stenosis